Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zeraim Gedera is a prominent Israeli agricultural biotechnology company that specializes in the development and production of high-quality hybrid vegetable seeds. Established in 1952 and headquartered in Revadim, the company focuses on breeding programs for key crops including tomatoes, peppers, cucumbers, and melons. In 2007, Zeraim Gedera was acquired by the global agribusiness leader Syngenta, allowing it to expand its international reach and integrate advanced genomic tools into its breeding processes. The company is recognized for its innovation in creating varieties with improved shelf life, disease resistance, and flavor profiles tailored for diverse global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zeraim Gedera.